Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  32,540 results for ""Mesalamine""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Physiologically Based Biopharmaceutics Modeling Coupled with Biopredictive Dissolution in Development of Bioequivalent Formulation for Mesalamine Enteric Coated Tablet: A Tough Nut to Crack.

  • Authors : Kollipara S; Biopharmaceutics Group, Global Clinical Management, Dr. Reddy's Laboratories Ltd., Integrated Product Development Organization (IPDO), Bachupally, Medchal Malkajgiri District, Hyderabad, 500090, Telangana, India. .; Prabhat PK

Subjects: Mesalamine*/Mesalamine*/Mesalamine*/pharmacokinetics ; Mesalamine*/Mesalamine*/Mesalamine*/administration & dosage ; Mesalamine*/Mesalamine*/Mesalamine*/chemistry

  • Source: AAPS PharmSciTech [AAPS PharmSciTech] 2024 Dec 02; Vol. 26 (1), pp. 1. Date of Electronic Publication: 2024 Dec 02.Publisher: Springer Country of Publication: United States NLM ID: 100960111 Publication Model: Electronic Cited Medium: Internet ISSN: 1530-9932

Record details

Read More Add to Saved list
×
Academic Journal

Randomized double-blind placebo-controlled study to evaluate the effect of long-acting mesalamine on postinfectious irritable bowel syndrome with diarrhea.

  • Authors : Tuteja AK; George E. Whalen Veterans Affairs Medical Center, Salt Lake City, Utah, USA.; Divisions of Gastroenterology, University of Utah, Salt Lake City, Utah, USA.

Subjects: Irritable Bowel Syndrome*/Irritable Bowel Syndrome*/Irritable Bowel Syndrome*/drug therapy ; Irritable Bowel Syndrome*/Irritable Bowel Syndrome*/Irritable Bowel Syndrome*/complications ; Mesalamine*/Mesalamine*/Mesalamine*/therapeutic use

  • Source: Neurogastroenterology and motility [Neurogastroenterol Motil] 2024 Oct; Vol. 36 (10), pp. e14889. Date of Electronic Publication: 2024 Aug 05.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 9432572 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Pentoxifylline in patients with ulcerative colitis treated with mesalamine by modulation of IL-6/STAT3, ZO-1, and S1P pathways: a randomized controlled double-blinded study.

  • Authors : Bahaa MM; Pharmacy Practice Department, Faculty of Pharmacy, Horus University, New Damietta, Egypt. .; Hegazy SK

Subjects: Colitis, Ulcerative*/Colitis, Ulcerative*/Colitis, Ulcerative*/drug therapy ; Colitis, Ulcerative*/Colitis, Ulcerative*/Colitis, Ulcerative*/metabolism ; STAT3 Transcription Factor*/STAT3 Transcription Factor*/STAT3 Transcription Factor*/metabolism

  • Source: Inflammopharmacology [Inflammopharmacology] 2024 Oct; Vol. 32 (5), pp. 3247-3258. Date of Electronic Publication: 2024 Aug 27.Publisher: Birkhäuser Country of Publication: Switzerland NLM ID: 9112626 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Mesalamine loaded ethyl cellulose nanoparticles: optimization and in vivo evaluation of antioxidant potential in ulcerative colitis.

  • Authors : Gautam P; Faculty of Pharmacy, DIT University, Mussoorie, Diversion Road, Makkawala, Uttarakhand 248009, India.; Hygia Institute of Pharmaceutical education and research, Faizullahganj, Prabandh Nagar, Ghaila road, Lucknow 226020, India.

Subjects: Mesalamine*/Mesalamine*/Mesalamine*/chemistry ; Mesalamine*/Mesalamine*/Mesalamine*/administration & dosage ; Cellulose*/Cellulose*/Cellulose*/chemistry

  • Source: Biomedical materials (Bristol, England) [Biomed Mater] 2024 Nov 22; Vol. 20 (1). Date of Electronic Publication: 2024 Nov 22.Publisher: Institute of Physics Pub Country of Publication: England NLM ID: 101285195 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A case of mesalamine potentiating hypoprothrombinemic effect of vitamin K antagonist (VKA) therapy resulting in life-threatening bleeding.

  • Authors : Prabhu RS; Department of Clinical Hematology, IQRAA International Hospital and Research Center, Malaparamba, Kozhikode, Kerala, India.; Rahmathullah SN

Subjects: Gastrointestinal Hemorrhage*/Gastrointestinal Hemorrhage*/Gastrointestinal Hemorrhage*/chemically induced ; Vitamin K*/Vitamin K*/Vitamin K*/antagonists & inhibitors ; Mesalamine*/Mesalamine*/Mesalamine*/adverse effects

  • Source: Journal of postgraduate medicine [J Postgrad Med] 2024 Oct 01; Vol. 70 (4), pp. 249-251. Date of Electronic Publication: 2024 Dec 11.Publisher: Medknow Publications Country of Publication: India NLM ID: 2985196R Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Effects of Mesalamine Combined with Live Combined Bifidobacterium, Lactobacillus and Enterococcus Capsules on Intestinal Mucosa Barrier Function and Intestinal Microbiota in Mildly Active Crohn's Disease Patients.

  • Authors : Shen M; Department of Gastroenterology, Nantong First People's Hospital, Nantong, Jiangsu, China.; Shi Y

Subjects: Crohn Disease*/Crohn Disease*/Crohn Disease*/drug therapy ; Mesalamine*/Mesalamine*/Mesalamine*/pharmacology; Humans

  • Source: Journal of investigative surgery : the official journal of the Academy of Surgical Research [J Invest Surg] 2024 Dec; Vol. 37 (1), pp. 2297565. Date of Electronic Publication: 2023Publisher: Taylor & Francis Country of Publication: United States NLM ID: 8809255 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Connect Read More Add to Saved list
×
Academic Journal

MMX mesalamine in ulcerative colitis: Major advantages towards classical mesalamine formulations.

  • Authors : D'Amico F; Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy.; Lusetti F

Subjects: Colitis, Ulcerative*/Colitis, Ulcerative*/Colitis, Ulcerative*/drug therapy ; Mesalamine*/Mesalamine*/Mesalamine*/administration & dosage ; Mesalamine*/Mesalamine*/Mesalamine*/therapeutic use

  • Source: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2024 Sep; Vol. 56 (9), pp.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 100958385 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Film Coating of Phosphorylated Mandua Starch on Matrix Tablets for pH-Sensitive Release of Mesalamine.

  • Authors : Malik MK; Department of Chemistry, Gurukula Kangri (Deemed to be University), Haridwar 249407, India.; Kumar V

Subjects: Mesalamine*/Mesalamine*/Mesalamine*/chemistry ; Mesalamine*/Mesalamine*/Mesalamine*/pharmacokinetics ; Starch*/Starch*/Starch*/chemistry

  • Source: Molecules (Basel, Switzerland) [Molecules] 2024 Jul 05; Vol. 29 (13). Date of Electronic Publication: 2024 Jul 05.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

Read More Add to Saved list
×
Academic Journal

Repurposing metformin as adjuvant therapy in patients with ulcerative colitis treated with mesalamine: A randomized controlled double-blinded study.

  • Authors : El-Haggar SM; Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University, El-Guiesh Street, El-Gharbia Government, Tanta 31527, Egypt.; Hegazy SK

Subjects: Metformin*/Metformin*/Metformin*/therapeutic use ; Colitis, Ulcerative*/Colitis, Ulcerative*/Colitis, Ulcerative*/drug therapy ; Mesalamine*/Mesalamine*/Mesalamine*/therapeutic use

  • Source: International immunopharmacology [Int Immunopharmacol] 2024 Sep 10; Vol. 138, pp. 112541. Date of Electronic Publication: 2024 Jun 24.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

MMX mesalamine: A modern twist on a classic treatment.

  • Authors : Nardone OM; Gastroenterology, Department of Public Health University of Naples Federico II, Italy. Electronic address: .

Subjects: Anti-Inflammatory Agents, Non-Steroidal*/Anti-Inflammatory Agents, Non-Steroidal*/Anti-Inflammatory Agents, Non-Steroidal*/adverse effects ; Anti-Inflammatory Agents, Non-Steroidal*/Anti-Inflammatory Agents, Non-Steroidal*/Anti-Inflammatory Agents, Non-Steroidal*/therapeutic use ; Mesalamine*/Mesalamine*/Mesalamine*/therapeutic use

  • Source: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2024 Sep; Vol. 56 (9), pp.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 100958385 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  32,540 results for ""Mesalamine""